History

On January 23, 2022, Governor Wang Hao and his delegation visited the company for research.

In April 2022, Comrade Fu Bangwu was awarded the "National May Day Labor Medal" and went to Hangzhou to receive the award.

On April 25, 2022, the 18th meeting of the 3rd Board of Directors and the 15th meeting of the 3rd Board of Supervisors were held.

In May 2022, the second phase of the health industry park completed its civil engineering project and began trial production.

On May 13, 2022, Yuan Jiajun, former Secretary of the Provincial Party Committee, and a delegation visited the company for research.

On May 16, 2022, the 2021 annual shareholders' meeting was held, and members of the fourth board of directors and the fourth board of supervisors were elected.

On June 16, 2022, General Manager Zhao Chunjian signed a contract with General Manager Ma Yunpeng of McKen Pharmaceutical (Dalian) Co., Ltd. in Dongtou.

On July 23, 2022, the brand new packaging design of "Virgo" ammonia sugar "0.48 grams × The launch ceremony of the national sales market of "24 capsules/box" was held at the Dongtou Manufacturing Department.

On August 17, 2022, the company's "Fish Oil Soft Capsule Health Food" passed the on-site inspection of the production license by the Zhejiang Provincial Market Supervision Administration.

On August 24, 2022, obtained the first "Health Food Production License" in Wenzhou City.

On August 26, 2022, the company successfully signed a cooperation agreement with the Provincial Institute of Asian Studies.

On August 27, 2022, the Party Committee of Chengyi Pharmaceutical held a general meeting of all Party members.

On September 19, 2022, a delegation led by Ding Jian, academician of the Chinese Academy of Engineering, Zhang Haiyan and Huang Chenggang, researchers of the Chinese Academy of Sciences Shanghai Institute of Materia Medica, visited the Zhejiang headquarters of chengyi Pharmaceutical to give special technical guidance to the company's "research and innovation projects".

On October 24, 2022, the company was listed as one of the first batch of key chemical monitoring points in Zhejiang Province, laying the foundation for the company's future projects and long-term development.

On December 20, 2022, at the launch ceremony of "Yingyangji" in Kunming, Yunnan, the new packaging "0.48 grams × 90 capsules/bottle of ammonia sugar has been launched in Kunming.

In 2022, the stock has raised its limit seven times, and investors are optimistic about the company's market prospects.

On January 19, 2021, the company reached a cooperation with Shanghai Ruijin Hospital, a well-known hospital in China, to jointly develop a pancreatic duct stent, a cross shaped flushing and drainage tube, and a new type of drainage and flushing tube.

On March 9, 2021, the small capacity injection workshop (i.e. Workshop 105) of the company's new formulation building passed the GMP compliance inspection of the Zhejiang Provincial Drug Administration,

On March 22, 2021, the company held a "Charity Day Donation" donation ceremony at the R&D building square.

On March 24, 2021, Wenzhou Municipal Party Committee and Wenzhou Municipal Government announced and commended a batch of "advanced collectives and exemplary individual promoting high-quality development in Wenzhou", and the company won the title of advanced collectives.

On April 9, 2021, the mask workshop (301 workshop) successfully passed the registration inspection and obtained a medical device production license. The disposable medical masks produced by the mask workshop were officially approved for sale

On May 29, 2021, the "Red Classic Theme Song Festival" jointly organized by the company's party and government work group kicked off.

On June 26, 2021, the celebration conference for the 100th anniversary of the founding of the Communist Party of China was held.

On September 15, 2021, Yao Gaoyuan, Deputy Secretary of the Municipal Party Committee and Mayor, and his delegation came to the company to conduct research on the marine economy.

On October 28, 2021, Guangzhou Sandaoyuan Pharmaceutical Technology Co., Ltd. was established.

On November 10, 2021, the company developed and produced two specifications of tolasemide injection (2ml: 10mg, 4ml: 20mg), which passed the national generic drug consistency evaluation and became the first similar product in China to pass the evaluation.

On November 12, 2021, the company's annual production of 1000 tons of ultra-high purity EPA fish oil workshop began construction for three months and reached its peak.

On November 15, 2021, the company signed a contract with Nanjing Newway Biotechnology Co., Ltd. to actively expand the "three-year plan" for the Chinese market of Tolasemide injection.

In early December 2021, the aspartate ornithine injection produced by the company obtained the "Drug Registration Certificate" approved and issued by the National Drug Administration.

On December 14, 2021, the Wenzhou Municipal Bureau of Economy and Information Technology announced the list of 44 intelligent factories (digital workshops) in the city, and Chengyi Pharmaceutical was listed. At the same time, it was rated as the "2021 Provincial New Generation Information Technology and Manufacturing Integration Development Pilot Demonstration Enterprise".

In 2021, the company was rated as the "first batch of most beautiful factories" in Wenzhou City, once again advancing into the ranks of "Wenzhou Comprehensive Top 100 Enterprises" and "Top 50 Manufacturing Enterprises", actively participating in the construction of the "black box" system for drug safety supervision in the province, and completing the ERP phase II management system.

In January 23, 2020,In the afternoon of the outbreak of "COVID-19" epidemic in Wuhan, the company issued the No. 18 document - Notice on the Prevention of novel coronavirus drafted by President Zhao to actively deploy epidemic prevention and resistance.

In January 27, 2020,On the third day of the Chinese New Year, after careful consideration and research, and under the conditions of epidemic prevention and control, the company decided to resume work and production ahead of schedule. Therefore, the company organized over 100 employees in Workshop 101 and logistics, security, QA, QC, and logistics personnel to work overtime to produce ribavirin preparations.

In March 11, 2020,In the morning, Chen Weijun, a member of the Standing Committee of the Provincial Party Committee and Secretary of the Wenzhou Municipal Party Committee, came to the company for research and guidance, carrying out the research task of the "Three Strong and Two Promotions" special activity.

In March 19, 2020,In the evening, the company announced that one of its main products, glucosamine hydrochloride capsules (with specifications of 480mg and 750mg), had passed the quality and efficacy consistency evaluation of generic drugs, making it the first in China.

In April 16, 2020,Wenzhou Municipal Party Committee issued a document, awarding the company "Advanced Collective for the Establishment of Two Health Pioneers", and awarding the chairman Yan Yiyi "exemplary individual for the Establishment of Two Health Pioneers".

In May 5, 2020,The antiviral drug ribavirin of the company was listed in the Diagnosis and Treatment Plan for novel coronavirus (fifth edition) by the National Health and Family Planning Commission.

In May 18, 2020,In response to the decisions of the provincial and municipal party committees, all companies have resumed work.

In May 22, 2020,The company announced that it plans to acquire no more than 35% of the equity of Zhejiang Kangle Pharmaceutical Co., Ltd. at a price of no more than 8 yuan per share through Block trade, agreement transfer or competitive trading.

In May 27, 2020,At 9:30 am, Chen Yijun, Deputy Governor of the Provincial People's Government, and his delegation came to the company for inspection and guidance.

In June 18, 2020,The opening price of the company's stock in the morning was 25.52 yuan, and it closed at 3 pm with a limit up of 27.04 yuan. Up 10.01%. This is the third time the limit has been raised this year.

In July 17-18, 2020,Led by Yan Dong and General Manager Zhao, cadres with the rank of Assistant General Manager or above at the headquarters of the company and Vice General Manager or above at the branch and subsidiary levels were dispatched to Fujian Huakang Pharmaceutical Co., Ltd. to hold a "Half Year Production and Operation Meeting".

In August 19, 2020,The company's stock price has entered a limit up. On August 18th, the closing price was 25.29, and it was opened at 25.70 today. The market was closed until the morning, with 19700 hands closed. Today's limit up price was 27.82 yuan. This is the fourth time the limit has been raised this year.

In September 7th, 2020,The company has officially launched an "online mall" in the "Yaoqi Cloud Library" mall, and Mr. Zhao presided over a brief opening ceremony on the first floor of the company's R&D building.

In October 16, 2020,In the morning, the "Chengyi Class" jointly organized by the company and China Pharmaceutical University held a grand opening ceremony.

In November 5th, 2020,Yan Dong attended the Second Dongtou District Private Entrepreneur Festival Celebration Conference and Outstanding Private Entrepreneur Commendation Conference held by the Dongtou District Committee and Government, and was awarded the title of "Excellent Private Entrepreneur".

In December 22, 2020,The list of "2020 Wenzhou Top 100 Comprehensive Strength Enterprises" and "2020 Wenzhou Top 50 Manufacturing Enterprises" jointly evaluated by the Wenzhou Enterprise Federation, Industrial Federation, and Entrepreneur Association has been announced, and the company has respectively entered the Comprehensive Top 100 and Manufacturing Top 50. Mr. Zhao was elected as an excellent entrepreneur in Wenzhou City in 2020.

In 2019,Tax payment is 85.51 million yuan. In February, he was appointed by the Dongtou District Committee. The district government has been awarded the title of "Dongtou District Marine Economic Development Meritorious Enterprise".

In July 2019,Selected for the first time in the top 100 list of China's chemical pharmaceutical industry.

In September 30, 2019,The company has moved into the R&D building of the "Health Industry Park" as a whole to work.

In November 2019,Rated as a "Zhejiang Province Cloud Benchmark Enterprise" by the Zhejiang Provincial Department of Economy and Information Technology.

In January 10, 2018,At 11: 00 a.m., a piling ceremony was held for the Sincere Pharmaceutical Health Industrial Park (that is, the technical renovation project) with a total investment of nearly 500 million yuan.

In March 7, 2018,At 5: 30 in the afternoon, at the New Century Hotel in Dongtou, the people's government of Dongtou District presided over the ceremony. Yan Yiyi, the chairman of the board, formally signed a contract with Ding Jian, an academician of China Academy of Engineering, to establish the "Expert Workstation of Chengyi Pharmaceutical Academician".

In June 19, 2018,At 10: 00 a.m., the company held the ceremony of entering the marketing center, technology development center and securities affairs center in R&F Center of Shanghai Hongqiao Business District. In his speech, Yan Yiyi, Chairman of the Board of Directors, said that the "Three Centers" settled in "Dahongqiao", which was a platform for the company to jump from "sea" to Shanghai, thus facilitating its foothold in an international metropolis, realizing talent gathering, resource integration and sales radiation, and at the same time taking the first step of "marketing reform".

In December 08, 2018,At the 13th conference of "Investigation and Selection of Competitiveness and Credibility of Listed Companies in China" held in Nanjing, the jury evaluated Chengyi Pharmaceutical as "the best listed company with market value management" according to the indexes such as the maintenance, management and promotion of stock market value by enterprises.

In 2017,What are the financial competitiveness of the 17 Wenzhou manufacturing companies listed on the A-share market? After a comprehensive analysis of 21 indicators of financial competitiveness, Wenzhou Investigation Team of National Bureau of Statistics ranked Chengyi Pharmaceutical No.1 in financial competitiveness and No.18 among 322 manufacturing companies in the province.

In March 15, 2017,In the morning, the listing ceremony of Zhejiang Chengyi Pharmaceutical Co., Ltd. was held in Shanghai Stock Exchange. The company's stock officially landed in the A-share main board market of Shanghai Stock Exchange. The stock name is Chengxin Pharmaceutical, and the stock code is 603811.

In October 19, 2017,Zhao Chunjian, assistant to the chairman of Zhejiang Chengyi Pharmaceutical Co., Ltd., was elected as the chairman of the first Federation of Industry and Commerce in Dongtou District and the president of the General Chamber of Commerce.

In November 29, 2017,Zhejiang Chengyi Pharmaceutical Co., Ltd. held a promotion meeting of Danyining tablets, the exclusive Chinese medicine variety in Guangzhou, to attract investment for the first time in China; At the end of December, the company's fundraising project-Chengyi Pharmaceutical Health Industrial Park officially started.

In October 19, 2016,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. started its 50th anniversary celebration. At the "Zhejiang Marine Biomedical Forum", academic reports of experts and scholars such as Yang Huanming, academician of Chinese Academy of Sciences, and Chen Shifei, deputy director of Zhejiang Food and Drug Administration were brilliant; Artists from china opera presented a literary program, Blessing on the Horizon.

In April 8, 2015,Zhejiang Drug Certification and Inspection Center sent staff to the company to carry out GMP certification inspection on 6 workshops including 102, 201, 205, 206, 207 and 208.

In August 18, 2015,The technical transformation project of Zhejiang Cheng Yi Pharmaceutical Co., Ltd.-500 tons glucosamine hydrochloride raw material medicine and preparation building project passed the environmental protection acceptance.

In November 6, 2015,The National Drug Certification and Inspection Center sent personnel to the company to follow up and audit Amikacin Sulfate Injection.

In January 2014,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was recognized by the Ministry of Industry and Information Technology as one of the top 300 companies in the national pharmaceutical industry with total profits. Yan Yiyi, Chairman of the Board of Directors, was named "Outstanding Entrepreneur of Wenzhou City in 2013" by Wenzhou Municipal Party Committee and Municipal Government, and the following year, Chairman Yan Yiyi won this honor again.

In the same year,the FDA audited three products of the company, such as ribavirin and thioprine.

In March 24, 2013,In order to enter the capital market, Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was renamed as Zhejiang Chengyi Pharmaceutical Co., Ltd. and held a listing ceremony.

In November 27th, 2013,Sulfur file purine passed GMP certification in Germany; In the same year, ribavirin and thioprine passed GMP certification in Australia.

In the same year,the company's technology research and development center was recognized as the provincial high-tech enterprise research and development center.

In February 2012,The workshops 203 and 205 of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. passed the national GMP certification review. In December, the technical transformation project of ribavirin and other products produced by Zhejiang Cheng Yi Pharmaceutical Co., Ltd. passed the on-site completion acceptance organized by Zhejiang Environmental Protection Department.

In July 1, 2011,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. signed an agreement with Shandong Guangbo Biotechnology Service Co., Ltd. to further improve the phosphorus-containing treatment capacity of the technical transformation project-Three Wastes Treatment Center.

In September 22, 2011,torasemide products passed the national GMP certification inspection.

In the same year,mesalazine was successfully developed and put into production.

In September 7-9, 2010,Joint audit officials from "four countries and three parties" such as FDA, EMEA, TGA and Singapore National Drug Administration came to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. to conduct on-site audit and certification of three APIs, such as ribavirin and thioprine. By February 2011, they received certification certificates one after another. This authentication method is the first in the global pharmaceutical industry.

In the same year,Yan Yiyi, the chairman of Zhejiang Cheng Yi Pharmaceutical Co., Ltd., was named "2009 Wenzhou Excellent Entrepreneur" by Wenzhou Municipal People's Government.

In August 28th, 2009,the Technology Research and Development Center of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was recognized as "Provincial Enterprise Technology Center" by Zhejiang Economic and Information Committee and Zhejiang Provincial Department of Finance.

In 2008,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was recognized as a national high-tech enterprise and enjoyed preferential income tax policies.

In October 2007,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was recognized by the Ministry of Science and Technology as the "Key High-tech Enterprise of the National Torch Program" in 2007. "Development of raw materials and preparations of torasemide" is included in the major scientific and technological projects of Zhejiang Province and Wenzhou City.

In 2006,the raw materials ribavirin and glucosamine hydrochloride produced by Zhejiang Cheng Yi Pharmaceutical Co., Ltd. passed the national GMP certification. "Development of raw materials and preparations of torasemide" is included in the "National Torch Plan Project".

In 2005,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. began to invest more than 30 million yuan to build an environmental protection public project-the three wastes treatment center. Enterprises have embarked on the road of sustainable development.

In April 8, 2004,Jiangsu Huai 'an Biological Branch of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was officially put into production.

In May 9, 2003,The then Secretary of Zhejiang Provincial Party Committee, accompanied by Wenzhou Municipal Party Committee Secretary Li Qiang and other leaders, visited Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

In the same year,Ribavirin and acyclovir produced by the company were recognized as "Zhejiang famous brand products".

In the same year,Chairman Yan Yiyi was elected as the representative of the 10th Zhejiang Provincial People's Congress.

In 2002,Zhejiang Cheng Yi Pharmaceutical Co., Ltd. passed the national GMP certification in an all-round way and became the first pharmaceutical enterprise in Wenzhou to pass the GMP certification in an all-round way. The enterprise was recognized as "Zhejiang High-tech Enterprise".

In March, 2001,Wenzhou No.3 Pharmaceutical Factory was rated as "Top 20 Enterprises in Zhejiang Pharmaceutical Industry in 2000" by Zhejiang Economic and Trade Commission.

In April, 2001,Wenzhou No.3 Pharmaceutical Factory was restructured into a joint-stock company and renamed as Zhejiang Cheng Yi Pharmaceutical Co., Ltd., with Yan Yiyi as the chairman.

In August 9, 2001,The company was officially listed and held a celebration meeting.

In November, 2000,The technical transformation project of Wenzhou No.3 Pharmaceutical Factory-the expansion of the preparation building was completed, and the construction area of the enterprise increased by 1,279 square meters.

In the same year,Wenzhou No.3 Pharmaceutical Factory was awarded the title of "five key enterprises" in Zhejiang Province by the provincial government.

In March 31, 1999,Zhang Dejiang, then secretary of Zhejiang Provincial Party Committee, came to Wenzhou No.3 Pharmaceutical Company for inspection and guidance.

In June, 1999,Yan Yiyi, director of Wenzhou No.3 Pharmaceutical Factory, was awarded the title of "Zhejiang Excellent Communist party member" by committee of cpc zhejiang provincial committee. In June 2001, Yan Yiyi won the title of "Excellent Communist party member of Zhejiang Province" again.

In March, 1998,In order to meet the inspection by the Australian Food and Drug Administration (TGA), the enterprise quality inspection center was expanded and completed in July.

In the same year,Acyclovir produced by Wenzhou No.3 Pharmaceutical Factory won the title of "High Quality Pharmaceutical Products" in Zhejiang Province in 1997.

In the same year,Director Yan Yiyi was elected as the vice chairman of Dongtou CPPCC.

In February 25th, 1997,Factory director Yan Yiyi was awarded "Jinlu Award" by the Municipal People's Government as the outstanding factory director of Wenzhou industrial enterprises in 1996. Since then, the factory director Yan Yiyi has won this honor for three consecutive years.

In June, 1996,The third pharmaceutical technical transformation project in Wenzhou-Ribavirin Capsule was put into production.

In July, 1995,The technical transformation project of Wenzhou No.3 Pharmaceutical Factory-Acyclovir Workshop was completed and put into operation.

In the same year,Wenzhou No.3 Pharmaceutical Company was awarded as "AAA Credit Enterprise in Zhejiang Province".

In March, 1994,the Dongtou County Party Committee and the county government approved Wenzhou No.3 Pharmaceutical Factory to be "publicly owned and privately run", with Yan Yiyi, Yan Sunchuan, Shen Ailan and Zhang Fufu as the leaders of "publicly owned and privately run".

In June, 1993, Chai Songyue, the then executive vice governor, visited Wenzhou No.3 Pharmaceutical Factory and sent a loan of 5 million yuan, which was urgently needed by the enterprise.

In February, 1992, Wenzhou No.3 Pharmaceutical Company carried out the third technological transformation, and invested 8.4 million yuan to build an acyclovir production workshop. Wenzhou No.3 Pharmaceutical Factory was rated as "Technological Progress Enterprise" by the provincial government.

In July 16, 1991, Tongshan Pharmaceutical Factory was renamed Wenzhou No.3 Pharmaceutical Factory.

In 1990, Tongshan Pharmaceutical Factory bid farewell to the old factory that had been producing in Xiaopu for 24 years, and moved to Houlong (the present site), and officially opened its office on January 20th.

In the same year, the output value of Tongshan Pharmaceutical Factory exceeded 10 million yuan for the first time.

In 1989,Tongshan Pharmaceutical Factory invested 2.5 million yuan to build an injection workshop in Houlong Village (now the factory site). The completion acceptance was passed on October 25th, and the first technical transformation was successfully completed.

In the same year,Yan Yiyi, the director of Tongshan Pharmaceutical Factory, was named "model worker of Wenzhou City".

In September 1988, Tongshan Pharmaceutical Factory passed the acceptance inspection of the Zhejiang Provincial Comprehensive Quality Management Acceptance Team and became the first "municipal advanced enterprise" in Dongtou.

In 1987, the "Lincomycin Hydrochloride" produced by Tongshan Pharmaceutical Factory was rated as the first of its kind in the province by the Zhejiang Provincial Medical Administration.

In 1985, Tongshan Pharmaceutical Factory passed the second provincial and municipal "two certificates" (drug production qualification certificate and drug production license) acceptance and obtained the issuance of certificates.

In 1982, Tongshan Pharmaceutical Factory carried out the "eight level salary system" reform, breaking the "iron rice bowl" system and becoming the "first" industrial enterprise in the province.

In October 1981, Tongshan Pharmaceutical Factory passed the first inspection of the pharmaceutical industry in Zhejiang Province and obtained a "business license".

In January 3, 1980, the Dongtou County Party Committee issued a document appointing Yan Yiyi as the factory director of Tongshan Pharmaceutical Factory. After three consecutive years of losses from 1977 to 1979, Tongshan Pharmaceutical Factory turned losses into profits for the first time in 1980.

In July 23, 1972, the Military Party Committee and Dongtou County Committee agreed to transfer Tongshan Pharmaceutical Factory from the military to local management.

In May 1971, Comrade Hu Zhiqun, the person in charge of Tongshan Pharmaceutical Factory, was awarded the title of "Jiao Yulu style good cadre" by the 6415 Army Party Committee. On May 11, the People's Front newspaper of the Nanjing Military Region published an article titled "Two Great Tanks Causing Revolution", praising Tongshan Pharmaceutical Factory's spirit of hard work and entrepreneurship.

In October 1966, Xiaopu Health Team of 6415 garrison troops founded Tongshan Pharmaceutical Factory, and the first product, aluminum hydroxide gel, was put into production. After three years of arduous research, the first injection product, berberine hydrochloride, was successfully trial-produced and put into mass production.